SHORT COMMUNICATION: Apolipoprotein E genotype and cognition in bipolar disorder.
Apolipoprotein E (APOE) has been extensively studied as a risk factor for sporadic and late onset Alzheimer's Disease (AD). APOE allele (∗)3, the most frequent variant, is not associated to cognitive dysfunction (CD) or to increased AD risk. Differently, the (∗)4 allele is a well-established risk factor for CD, while the (∗)2 allele is associated with survival and longevity. CD is an important feature of Bipolar Disorder (BD) and recent data suggest that CD may be one of its endophenotypes, although controversial results exist. The aim of this research is to study the association of APOE genotype (APOE) and neurocognitive function in a sample of drug free young BD-type I patients. Sample consisted of 25 symptomatic BD (type I) patients (age 18-35 years old). They were submitted to an extensive neuropsychological evaluation and genotyped for APOE. Subjects with allele (∗)2 presented better cognitive performance. The presence of allele (∗)4 was associated with worse performance in a few executive tasks. APOE (∗)3(∗)3 was associated with overall severe dysfunction on cognitive performance. In young individuals with nontreated BD-type I, APOE may predict cognitive performance. Further and larger studies on APOE and cognition in BD are required to clarify whether APOE is a BD cognitive endophenotype.
Soeira-de-Souza
Márcio Gerhardt
MG
Department and Institute of Psychiatry, University of São Paulo, Brazil. marciogss@hcnet.usp.br
Soeiro de Souza
Márcio Gerhardt
MG
Bio
Danielle Soares
DS
Dias
Vasco Videira
VV
Martins do Prado
Carolina
C
Campos
Rodolfo Nunes
RN
Costa
Luis Felipe de Oliveira
LF
Moreno
Doris Hupfeld
DH
Ojopi
Elida Benquique
EB
Gattaz
Wagner Farid
WF
Moreno
Ricardo Alberto
RA
D000293:Adolescent; D000328:Adult; D001057:Apolipoproteins E / Q000235:genetics*; D001714:Bipolar Disorder / Q000150:complications* / Q000235:genetics*; D003072:Cognition Disorders / Q000209:etiology* / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D055815:Young Adult
D001057:Apolipoproteins E
Arch Intern Med. 1991 Jan;151(1):75-8
1985611
Ann Neurol. 1996 Jan;39(1):62-70
8572669
Lancet. 1993 Sep 18;342(8873):697-9
8103819
Bipolar Disord. 2009 Jun;11(4):351-60
19500088
Behav Genet. 2001 Nov;31(6):489-95
11838528
Arch Neurol. 1996 May;53(5):418-22
8624216
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
14399272
Braz J Psychiatry. 2006 Sep;28(3):226-37
17063223
Biol Psychiatry. 1999 Feb 15;45(4):430-4
10071713
Nat Genet. 1998 Aug;19(4):321-2
9697689
Biol Psychiatry. 1996 Jul 1;40(1):69-71
8780857
Science. 2001 Nov 9;294(5545):1354-7
11701931
Neurobiol Aging. 2011 Jan;32(1):63-74
19285755
Adv Hum Genet. 1993;21:145-319
8391199
J Am Geriatr Soc. 1994 Sep;42(9):919-22
8064097
Br J Psychiatry. 1978 Nov;133:429-35
728692
Acta Neurol Scand. 1999 Jul;100(1):53-60
10416512
Biol Psychiatry. 1996 Nov 15;40(10):1008-16
8915560
Science. 1993 Aug 13;261(5123):921-3
8346443
Psychol Aging. 2004 Dec;19(4):592-600
15584785
Psychiatry Res. 2008 Feb 28;158(1):75-8
18096247
Nat Genet. 1994 Jan;6(1):29-32
8136829
Psychother Psychosom. 2000;69(1):2-18
10601830
Am J Hum Genet. 1994 Nov;55(5):1001-18
7977338
Lancet. 1993 Sep 18;342(8873):710-1
8103823
Obstet Gynecol. 1994 Jun;83(6):979-83
8190445
Biotechniques. 1994 Aug;17(2):316, 318, 320-2
7980935
Am J Hum Genet. 1996 Apr;58(4):803-11
8644745
Am J Psychiatry. 2003 Apr;160(4):636-45
12668349
Biol Psychiatry. 1997 Apr 15;41(8):912-3
9099420
Arch Neurol. 2002 Jul;59(7):1154-60
12117364
JAMA. 1993 May 26;269(20):2637-41
8487446
N Engl J Med. 2000 Aug 17;343(7):450-6
10944562
Neurosci Lett. 1997 Sep 12;233(1):45-8
9324236
Neurobiol Aging. 2004 May-Jun;25(5):651-60
15172744